Cite

APA Citation

    Estill, J., & Bertisch, B. (2020). more evidence for dolutegravir as first-line ART for all. Lancet, 7(3), e154–e155. http://access.bl.uk/ark:/81055/vdc_100103932538.0x000014
  
Back to record